AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Trump's Tariff Threat, Retail Earnings Ahead of Black Friday, Amgen Tumbles on Weight-Loss Drug Data 11/26/24
Squawk on the Street
Amgen's Weight Loss Drug Woes
This chapter examines Amgen's declining stock performance linked to concerns over its experimental weight loss drug and its mixed results in trials. It also discusses the broader market implications of the Biden administration's efforts to expand access to obesity treatments and the volatility in futures trading.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode